TVTX - CIK 0001438533
Travere Therapeutics, Inc. has filed 1,240 documents with the SEC between 2008 and 2026. The most frequent type is insider trade (504 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider sale notice | 144 | 2025-01-22 | - |
| Major company event | 8-K | 2025-01-13 | 2025-01-13 |
| Insider trade | 4 | 2025-01-06 | 2025-01-03 |
| Insider trade | 4 | 2024-12-27 | 2024-12-26 |
| Insider sale notice | 144 | 2024-12-26 | - |
| Insider sale notice | 144 | 2024-11-25 | - |
| Insider trade | 4 | 2024-11-25 | 2024-11-25 |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| Passive ownership stake | SC 13G | 2024-11-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-12 | - |
| Major company event | 8-K | 2024-11-08 | 2024-11-07 |
| Prospectus supplement | 424B5 | 2024-11-08 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-08 | - |
| Prospectus supplement | 424B5 | 2024-11-07 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-04 | - |
| Prospectus supplement | 424B5 | 2024-10-31 | - |
| Quarterly report | 10-Q | 2024-10-31 | 2024-09-30 |
| Major company event | 8-K | 2024-10-31 | 2024-10-31 |
| Passive ownership stake (update) | SC 13G/A | 2024-10-18 | - |
| Insider sale notice | 144 | 2024-10-04 | - |
| Insider trade | 4 | 2024-10-04 | 2024-10-04 |
| Insider sale notice | 144 | 2024-09-30 | - |
| Insider trade | 4 | 2024-09-30 | 2024-09-30 |
| Major company event | 8-K | 2024-09-26 | 2024-09-26 |
| Insider sale notice | 144 | 2024-09-11 | - |
| Insider trade | 4 | 2024-09-10 | 2024-09-10 |
| Insider sale notice | 144 | 2024-09-09 | - |
| Insider sale notice | 144 | 2024-09-09 | - |
| Insider sale notice | 144 | 2024-09-09 | - |
| Insider trade | 4 | 2024-09-09 | 2024-09-05 |
| Insider trade | 4 | 2024-09-09 | 2024-09-05 |
| Insider trade | 4 | 2024-09-09 | 2024-09-05 |
| Insider trade | 4 | 2024-09-09 | 2024-09-05 |
| Insider trade | 4 | 2024-09-09 | 2024-09-05 |
| Insider trade | 4 | 2024-09-09 | 2024-09-05 |
| Major company event | 8-K | 2024-09-06 | 2024-09-05 |
| Insider trade | 4 | 2024-09-05 | 2024-09-04 |
| Quarterly report | 10-Q | 2024-08-01 | 2024-06-30 |
| Major company event | 8-K | 2024-08-01 | 2024-08-01 |
| S-3ASR | - | 2024-08-01 | - |
| Employee stock plan | S-8 | 2024-06-14 | - |
| Major company event | 8-K | 2024-05-13 | 2024-05-08 |
| Insider trade | 4 | 2024-05-10 | 2024-05-08 |
| Insider trade | 4 | 2024-05-10 | 2024-05-08 |
| Insider trade | 4 | 2024-05-10 | 2024-05-08 |
| Insider trade | 4 | 2024-05-10 | 2024-05-08 |
| Insider trade | 4 | 2024-05-10 | 2024-05-08 |
| Insider trade | 4 | 2024-05-10 | 2024-05-08 |
| Insider trade | 4 | 2024-05-10 | 2024-05-08 |